Appili Therapeutics Inc (APLIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 10 | 1,109 | 4 | 13 | 31 |
| Gross Profit | 10 | 1,109 | 4 | 13 | 31 |
| Operating Expenses | 2,078 | 3,472 | 9,004 | 6,199 | 4,335 |
| Operating Income | -2,068 | -2,363 | -9,000 | -6,185 | -4,304 |
| Other Income | -523 | -200 | 128 | 202 | 454 |
| Pre-tax Income | -2,591 | -2,563 | -8,872 | -5,983 | -3,850 |
| Income Tax | -1 | 7 | 7 | 17 | N/A |
| Net Income Continuous | -2,590 | -2,570 | -8,879 | -6,000 | -3,850 |
| Net Income | $-2,590 | $-2,570 | $-8,879 | $-6,000 | $-3,850 |
| EPS Basic Total Ops | -0.02 | -0.04 | -0.14 | -0.10 | -0.06 |
| EPS Basic Continuous Ops | -0.03 | -0.04 | -0.14 | -0.10 | -0.06 |
| EPS Diluted Total Ops | -0.02 | -0.04 | -0.14 | -0.10 | -0.06 |
| EPS Diluted Continuous Ops | -0.03 | -0.04 | -0.14 | -0.10 | -0.06 |
| EBITDA(a) | $-2,065 | $-2,360 | $-8,998 | $-6,183 | $-4,301 |